Customize your search results with filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 03/06/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 297532 publications
Progressive eosinophilia and STAT5B mutation acquisition in AML treated with azacitidine and venetoclax.
Journal: Leukemia & lymphoma
Published: February 04, 2025
The Diagnostic Spectrum of Myelodysplastic Syndromes and Acute Myeloid Leukemia.
Journal: Advances in anatomic pathology
Published: February 03, 2025
Fenretinide targets GATA1 to induce cytotoxicity in GATA1 positive Acute Erythroid and Acute Megakaryoblastic Leukemic cells.
Journal: bioRxiv : the preprint server for biology
Published: February 03, 2025
Phlegmonous gastritis in a patient with chemotherapy induced neutropenia
Journal: Medicina
Published: February 03, 2025
T-cell neoplasias and secondary malignancies after CAR-T cell therapy: current knowledge, risk factors, and implications from CAR-T engineering strategies.
Journal: Leukemia & lymphoma
Published: February 03, 2025
Genetically Distinct Acute Megakaryoblastic Leukemia following Low Hypodiploid B-Lymphoblastic Leukemia linked by TP53 Mutation.
Journal: Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society
Published: February 03, 2025
Loss of Fanconi anemia proteins causes a reliance on lysosomal exocytosis.
Journal: bioRxiv : the preprint server for biology
Published: February 03, 2025
CAR-T cell therapy in the treatment of relapsed or refractory primary central nervous system lymphoma: recent advances and challenges.
Journal: Leukemia & lymphoma
Published: February 03, 2025
RNA in Stow, Leukemia on the Go: P-Bodies RNA Sequestration Drives Leukemogenesis.
Journal: Cellular reprogramming
Published: February 03, 2025
Zn2+ triazamacrocyclic chelators with methylpyridine pendant arms for B-cell apoptosis: a structure-activity study.
Journal: Dalton transactions (Cambridge, England : 2003)
Published: February 03, 2025
Telomeric SUMO level influences the choices of APB formation pathways and ALT efficiency.
Journal: bioRxiv : the preprint server for biology
Published: February 03, 2025
Phase 2 study of alemtuzumab and dose-adjusted EPOCH-R in relapsed or refractory aggressive B-cell lymphomas.
Journal: Leukemia & lymphoma
Published: February 03, 2025
Last Updated: 03/06/2025